日本食管胃结合部腺癌内镜切除术后长期结局及异时性癌
该多中心回顾性分析纳入日本13家中心372例接受内镜切除的表浅食管胃结合部腺癌患者,按淋巴结转移风险分为低危277例和高危95例。低危组5年总生存率93.9%、疾病特异性生存率100%;EMR组5年局部复发累积发生率13%高于ESD组的0.5%(P<.01)。
要点
- 低危组未追加治疗者5年总生存率93.9%、疾病特异性生存率100%。
- EMR组5年局部复发累积发生率13% vs ESD组0.5%(P<.01)。
- 316例未追加治疗者5年异时性食管胃结合部腺癌累积发生率为1.1%。
核心结论
- 符合淋巴结转移低危标准的食管胃结合部腺癌患者内镜切除术后长期结局良好。
- ESD是日本患者合理且有效的治疗方法。
研究设计与样本
- 日本13家中心开展的回顾性分析,纳入接受内镜切除(EMR或ESD)的表浅食管胃结合部腺癌患者372例。
- 按组织学特征分为淋巴结转移低危组277例和高危组95例,计算异时性癌发生率及总生存率和疾病特异性生存率。
主要发现
- EMR组5年局部复发累积发生率为13%,ESD组为0.5%(P<.01)。
- 高危组观察到6例食管胃结合部腺癌死亡,低危组为0例。
- 低危未追加治疗组、高危追加治疗组和高危未追加治疗组的5年总生存率分别为93.9%、77.7%和81.6%。
- 上述3组的5年疾病特异性生存率分别为100%、94.4%和92.8%。
- 316例未追加治疗患者5年异时性食管胃结合部腺癌累积发生率为1.1%。
临床怎么用
- 原文结论认为,符合淋巴结转移低危标准的食管胃结合部腺癌患者内镜切除术后长期结局良好。
- 原文结论认为,ESD是日本患者合理且有效的治疗方法。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Endoscopic resection (ER) of superficial adenocarcinoma of the esophagogastric junction (AEGJ) has been shown to be safe and effective. However, long-term data in patients undergoing ER for superficial AEGJ in Japan are still limited. The aim of this study was to determine the effect of ER on survival and occurrence of metachronous cancer of patients with superficial AEGJ. METHODS: A retrospective analysis of patients who underwent or endoscopic submucosal dissection (ESD) for superficial AEJG in 13 centers in Japan was performed. The patients were classified as either low risk or high risk for lymph node metastasis based on histologic features. The incidence of metachronous AEGJ as well as overall survival and disease-specific survival rates were calculated. RESULTS: A total of 372 patients who underwent ER were included, in which 277 patients were low risk and 95 high risk for lymph node metastasis. Five-year cumulative incidences of local recurrence were 13% and .5% in the EMR and ESD groups, respectively (P < .01). Six AEGJ deaths were observed in the high-risk group and none in the low-risk group. The 5-year overall survival rates in the low-risk group without additional treatment, the high-risk group with additional treatment, and the high-risk group without additional treatment were 93.9%, 77.7%, and 81.6%, respectively. The 5-year disease-specific survival rates in the 3 groups were 100%, 94.4%, and 92.8%, respectively. The 5-year cumulative incidence of metachronous AEGJ in 316 patients without additional treatment was 1.1%. CONCLUSIONS: Favorable long-term outcomes with ER were observed in patients with AEGJ who met the low-risk criteria for lymph node metastasis. ESD was a reasonable and effective treatment in Japanese patients.
引用
- Abe S, Ishihara R, Takahashi H, et al. Long-term outcomes of endoscopic resection and metachronous cancer after endoscopic resection for adenocarcinoma of the esophagogastric junction in Japan. Gastrointest Endosc. 2018. PMID: 30576649. doi:10.1016/j.gie.2018.12.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。